logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$31.95 m
Price
0.19 USD
Change
2.86%
52 weeks high
0.60
52 weeks low
0.17

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.